BioCentury
ARTICLE | Clinical News

BCX-34: Filed IND

March 29, 1993 8:00 AM UTC

BioCryst Pharmaceuticals Inc. Product: BCX-34 purine nucleoside phosphorylase inhibitor Indication: Allergic contact dermatitis. Status: Filed IND ...